News

AddToAny

Google+ Facebook Twitter Twitter

Genetic changes associated with physical activity

The time we spend sitting, sleeping and moving is determined in part by our genes, University of Oxford researchers have shown.

In one of the most detailed projects of its kind, the scientists studied the activity of 91,105 UK Biobank participants who had previously worn an activity monitor on their wrist for a week.

The scientists taught machines to automatically identify active and sedentary life from the huge amounts of activity monitor data.

They then combined this data with UK Biobank genetic information to reveal 14 genetic regions related to activity, seven new to science, they report in Nature Communications.

The work paves the way for better understanding of sleep, physical activity, and their health consequences.

Further analysis of the human genetic data showed for the first time that increased physical activity causally lowers blood pressure.

Physical inactivity is a global public health threat estimated to cost healthcare systems $50bn a year. It is associated with a range of common diseases including obesity, diabetes and heart disease. Changes in sleep duration are linked to heart and metabolic diseases and psychiatric disorders.

The genetic analysis also showed overlap with neurodegenerative diseases, mental health wellbeing and brain structure, showing an important role for the central nervous system with respect to physical activity and sleep.

Dr Aiden Doherty, who led the work and is based at the Big Data Institute, University of Oxford, said: “How and why we move isn’t all about genes, but understanding the role genes play will help improve our understanding of the causes and consequences of physical inactivity.”

go.nature.com/2Gc7XQV

Related Articles

Discovering the double helix

A look back in time to the history of the discovery of DNA and its structure – work which would change medicine and science forever.

January: news in numbers

A breakdown of science news this month, in numbers.

Cancer Research Shutterstock

New genomics centre to open

Cancer Research UK and AstraZeneca have announced that they are opening a new centre in the UK, dedicated to realising the full potential of functional genomics in the discovery and development of new drugs for patients with cancer.

State-of-the-art pathology

A new state-of-the-art laboratory system for the Black Country Pathology Service (BCPS) has been announced.

Top